Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease.

A beta-lactamase-stable antibiotic, the oral penem FCE 22891 (ritipenem acoxil), was investigated for use in exacerbations of chronic obstructive pulmonary disease (COPD). Thirteen of the 15 COPD patients had a proven lower respiratory tract infection. Symptom scores and forced expiratory volumes in...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Boersma, W G, Puister, S M, van Altena, R, de Vries-Hospers, H G, Molinari, M, Koëter, G H
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1994
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284559/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8031062/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.4.872
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!